世界のアンジオテンシン変換酵素阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Angiotensin Converting Enzyme Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3807
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、アンジオテンシン変換酵素阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベナゼプリル（ロテンシン）、カプトプリル、エナラプリル（バソテック）、フォシノプリル、リシノプリル（プリニビル、ゼストリル）、モエキシプリル、ペリンドプリル、キナプリル（アキュプリル）、ラミプリル（アルタス）、トランドラプリル）、用途別市場規模（冠状動脈疾患、心不全、糖尿病、慢性腎臓病、心臓発作、強皮症、片頭痛、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アンジオテンシン変換酵素阻害剤の市場動向
・企業の競争状況、市場シェア
・アンジオテンシン変換酵素阻害剤の種類別市場規模と予測2016-2027（ベナゼプリル（ロテンシン）、カプトプリル、エナラプリル（バソテック）、フォシノプリル、リシノプリル（プリニビル、ゼストリル）、モエキシプリル、ペリンドプリル、キナプリル（アキュプリル）、ラミプリル（アルタス）、トランドラプリル）
・アンジオテンシン変換酵素阻害剤の用途別市場規模と予測2016-2027（冠状動脈疾患、心不全、糖尿病、慢性腎臓病、心臓発作、強皮症、片頭痛、その他）
・アンジオテンシン変換酵素阻害剤の北米市場規模2016-2027（アメリカ、カナダ）
・アンジオテンシン変換酵素阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アンジオテンシン変換酵素阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アンジオテンシン変換酵素阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・アンジオテンシン変換酵素阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、AstraZeneca、Novartis AG、Daiichi Sankyo, Inc、Sanofi、Merck、Abbott）
・結論

Angiotensin converting enzyme inhibitors (ACE inhibitors) are medications that slow (inhibit) the activity of the enzyme ACE, which decreases the production of angiotensin II.

Market Analysis and Insights: Global Angiotensin Converting Enzyme Inhibitors Market
The global Angiotensin Converting Enzyme Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Angiotensin Converting Enzyme Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Angiotensin Converting Enzyme Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Angiotensin Converting Enzyme Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Angiotensin Converting Enzyme Inhibitors market.

Global Angiotensin Converting Enzyme Inhibitors Scope and Market Size
Angiotensin Converting Enzyme Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin Converting Enzyme Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Benazepril (Lotensin)
Captopril
Enalapril (Vasotec)
Fosinopril
Lisinopril (Prinivil, Zestril)
Moexipril
Perindopril
Quinapril (Accupril)
Ramipril (Altace)
Trandolapril

Segment by Application
Coronary Artery Disease
Heart Failure
Diabetes
Chronic Kidney Diseases
Heart Attacks
Scleroderma
Migraines
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
AstraZeneca
Novartis AG
Daiichi Sankyo, Inc
Sanofi
Merck
Abbott

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Benazepril (Lotensin)
1.2.3 Captopril
1.2.4 Enalapril (Vasotec)
1.2.5 Fosinopril
1.2.6 Lisinopril (Prinivil, Zestril)
1.2.7 Moexipril
1.2.8 Perindopril
1.2.9 Quinapril (Accupril)
1.2.10 Ramipril (Altace)
1.2.11 Trandolapril
1.3 Market by Application
1.3.1 Global Angiotensin Converting Enzyme Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Coronary Artery Disease
1.3.3 Heart Failure
1.3.4 Diabetes
1.3.5 Chronic Kidney Diseases
1.3.6 Heart Attacks
1.3.7 Scleroderma
1.3.8 Migraines
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Angiotensin Converting Enzyme Inhibitors Market Perspective (2016-2027)
2.2 Angiotensin Converting Enzyme Inhibitors Growth Trends by Regions
2.2.1 Angiotensin Converting Enzyme Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Angiotensin Converting Enzyme Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Angiotensin Converting Enzyme Inhibitors Industry Dynamic
2.3.1 Angiotensin Converting Enzyme Inhibitors Market Trends
2.3.2 Angiotensin Converting Enzyme Inhibitors Market Drivers
2.3.3 Angiotensin Converting Enzyme Inhibitors Market Challenges
2.3.4 Angiotensin Converting Enzyme Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Angiotensin Converting Enzyme Inhibitors Players by Revenue
3.1.1 Global Top Angiotensin Converting Enzyme Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Angiotensin Converting Enzyme Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Angiotensin Converting Enzyme Inhibitors Revenue
3.4 Global Angiotensin Converting Enzyme Inhibitors Market Concentration Ratio
3.4.1 Global Angiotensin Converting Enzyme Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angiotensin Converting Enzyme Inhibitors Revenue in 2020
3.5 Angiotensin Converting Enzyme Inhibitors Key Players Head office and Area Served
3.6 Key Players Angiotensin Converting Enzyme Inhibitors Product Solution and Service
3.7 Date of Enter into Angiotensin Converting Enzyme Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Angiotensin Converting Enzyme Inhibitors Breakdown Data by Type
4.1 Global Angiotensin Converting Enzyme Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Type (2022-2027)

5 Angiotensin Converting Enzyme Inhibitors Breakdown Data by Application
5.1 Global Angiotensin Converting Enzyme Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Angiotensin Converting Enzyme Inhibitors Market Size (2016-2027)
6.2 North America Angiotensin Converting Enzyme Inhibitors Market Size by Type
6.2.1 North America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2027)
6.3 North America Angiotensin Converting Enzyme Inhibitors Market Size by Application
6.3.1 North America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2027)
6.4 North America Angiotensin Converting Enzyme Inhibitors Market Size by Country
6.4.1 North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Angiotensin Converting Enzyme Inhibitors Market Size (2016-2027)
7.2 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type
7.2.1 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2027)
7.3 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application
7.3.1 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2027)
7.4 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country
7.4.1 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Type
8.2.1 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Application
8.3.1 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Region
8.4.1 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Angiotensin Converting Enzyme Inhibitors Market Size (2016-2027)
9.2 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type
9.2.1 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application
9.3.1 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country
9.4.1 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Type
10.2.1 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Application
10.3.1 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Country
10.4.1 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Angiotensin Converting Enzyme Inhibitors Introduction
11.1.4 Pfizer Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Angiotensin Converting Enzyme Inhibitors Introduction
11.2.4 AstraZeneca Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Angiotensin Converting Enzyme Inhibitors Introduction
11.3.4 Novartis AG Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Daiichi Sankyo, Inc
11.4.1 Daiichi Sankyo, Inc Company Details
11.4.2 Daiichi Sankyo, Inc Business Overview
11.4.3 Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Introduction
11.4.4 Daiichi Sankyo, Inc Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
11.4.5 Daiichi Sankyo, Inc Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Angiotensin Converting Enzyme Inhibitors Introduction
11.5.4 Sanofi Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Angiotensin Converting Enzyme Inhibitors Introduction
11.6.4 Merck Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Angiotensin Converting Enzyme Inhibitors Introduction
11.7.4 Abbott Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
11.7.5 Abbott Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Benazepril (Lotensin)
Table 3. Key Players of Captopril
Table 4. Key Players of Enalapril (Vasotec)
Table 5. Key Players of Fosinopril
Table 6. Key Players of Lisinopril (Prinivil, Zestril)
Table 7. Key Players of Moexipril
Table 8. Key Players of Perindopril
Table 9. Key Players of Quinapril (Accupril)
Table 10. Key Players of Ramipril (Altace)
Table 11. Key Players of Trandolapril
Table 12. Global Angiotensin Converting Enzyme Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Angiotensin Converting Enzyme Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 14. Global Angiotensin Converting Enzyme Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 15. Global Angiotensin Converting Enzyme Inhibitors Market Share by Regions (2016-2021)
Table 16. Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 17. Global Angiotensin Converting Enzyme Inhibitors Market Share by Regions (2022-2027)
Table 18. Angiotensin Converting Enzyme Inhibitors Market Trends
Table 19. Angiotensin Converting Enzyme Inhibitors Market Drivers
Table 20. Angiotensin Converting Enzyme Inhibitors Market Challenges
Table 21. Angiotensin Converting Enzyme Inhibitors Market Restraints
Table 22. Global Angiotensin Converting Enzyme Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 23. Global Angiotensin Converting Enzyme Inhibitors Market Share by Players (2016-2021)
Table 24. Global Top Angiotensin Converting Enzyme Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Converting Enzyme Inhibitors as of 2020)
Table 25. Ranking of Global Top Angiotensin Converting Enzyme Inhibitors Companies by Revenue (US$ Million) in 2020
Table 26. Global 5 Largest Players Market Share by Angiotensin Converting Enzyme Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Angiotensin Converting Enzyme Inhibitors Product Solution and Service
Table 29. Date of Enter into Angiotensin Converting Enzyme Inhibitors Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 32. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Type (2016-2021)
Table 33. Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 34. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 35. Global Angiotensin Converting Enzyme Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 36. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Application (2016-2021)
Table 37. Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 38. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 39. North America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 40. North America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 41. North America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 42. North America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 43. North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 44. North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 45. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 46. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 47. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 48. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 49. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 50. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 52. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 54. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 56. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 57. Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 58. Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 59. Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 60. Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 61. Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 62. Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 64. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 66. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 67. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 68. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Angiotensin Converting Enzyme Inhibitors Product
Table 72. Pfizer Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. AstraZeneca Company Details
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Angiotensin Converting Enzyme Inhibitors Product
Table 77. AstraZeneca Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021) & (US$ Million)
Table 78. AstraZeneca Recent Development
Table 79. Novartis AG Company Details
Table 80. Novartis AG Business Overview
Table 81. Novartis AG Angiotensin Converting Enzyme Inhibitors Product
Table 82. Novartis AG Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021) & (US$ Million)
Table 83. Novartis AG Recent Development
Table 84. Daiichi Sankyo, Inc Company Details
Table 85. Daiichi Sankyo, Inc Business Overview
Table 86. Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Product
Table 87. Daiichi Sankyo, Inc Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021) & (US$ Million)
Table 88. Daiichi Sankyo, Inc Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Angiotensin Converting Enzyme Inhibitors Product
Table 92. Sanofi Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021) & (US$ Million)
Table 93. Sanofi Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Angiotensin Converting Enzyme Inhibitors Product
Table 97. Merck Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Abbott Company Details
Table 100. Abbott Business Overview
Table 101. Abbott Angiotensin Converting Enzyme Inhibitors Product
Table 102. Abbott Revenue in Angiotensin Converting Enzyme Inhibitors Business (2016-2021) & (US$ Million)
Table 103. Abbott Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Angiotensin Converting Enzyme Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Benazepril (Lotensin) Features
Figure 3. Captopril Features
Figure 4. Enalapril (Vasotec) Features
Figure 5. Fosinopril Features
Figure 6. Lisinopril (Prinivil, Zestril) Features
Figure 7. Moexipril Features
Figure 8. Perindopril Features
Figure 9. Quinapril (Accupril) Features
Figure 10. Ramipril (Altace) Features
Figure 11. Trandolapril Features
Figure 12. Global Angiotensin Converting Enzyme Inhibitors Market Share by Application: 2020 VS 2027
Figure 13. Coronary Artery Disease Case Studies
Figure 14. Heart Failure Case Studies
Figure 15. Diabetes Case Studies
Figure 16. Chronic Kidney Diseases Case Studies
Figure 17. Heart Attacks Case Studies
Figure 18. Scleroderma Case Studies
Figure 19. Migraines Case Studies
Figure 20. Others Case Studies
Figure 21. Angiotensin Converting Enzyme Inhibitors Report Years Considered
Figure 22. Global Angiotensin Converting Enzyme Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 23. Global Angiotensin Converting Enzyme Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 24. Global Angiotensin Converting Enzyme Inhibitors Market Share by Regions: 2020 VS 2027
Figure 25. Global Angiotensin Converting Enzyme Inhibitors Market Share by Regions (2022-2027)
Figure 26. Global Angiotensin Converting Enzyme Inhibitors Market Share by Players in 2020
Figure 27. Global Top Angiotensin Converting Enzyme Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Converting Enzyme Inhibitors as of 2020
Figure 28. The Top 10 and 5 Players Market Share by Angiotensin Converting Enzyme Inhibitors Revenue in 2020
Figure 29. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Type (2016-2021)
Figure 30. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Type (2022-2027)
Figure 31. North America Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. North America Angiotensin Converting Enzyme Inhibitors Market Share by Type (2016-2027)
Figure 33. North America Angiotensin Converting Enzyme Inhibitors Market Share by Application (2016-2027)
Figure 34. North America Angiotensin Converting Enzyme Inhibitors Market Share by Country (2016-2027)
Figure 35. United States Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Canada Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Europe Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Europe Angiotensin Converting Enzyme Inhibitors Market Share by Type (2016-2027)
Figure 39. Europe Angiotensin Converting Enzyme Inhibitors Market Share by Application (2016-2027)
Figure 40. Europe Angiotensin Converting Enzyme Inhibitors Market Share by Country (2016-2027)
Figure 41. Germany Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. France Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. U.K. Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Italy Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Russia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Nordic Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Share by Type (2016-2027)
Figure 49. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Share by Application (2016-2027)
Figure 50. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Share by Region (2016-2027)
Figure 51. China Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Japan Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. South Korea Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Southeast Asia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. India Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Australia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Latin America Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Latin America Angiotensin Converting Enzyme Inhibitors Market Share by Type (2016-2027)
Figure 59. Latin America Angiotensin Converting Enzyme Inhibitors Market Share by Application (2016-2027)
Figure 60. Latin America Angiotensin Converting Enzyme Inhibitors Market Share by Country (2016-2027)
Figure 61. Mexico Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Brazil Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Share by Type (2016-2027)
Figure 65. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Share by Application (2016-2027)
Figure 66. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Share by Country (2016-2027)
Figure 67. Turkey Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 68. Saudi Arabia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 69. UAE Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 70. Pfizer Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
Figure 71. AstraZeneca Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
Figure 72. Novartis AG Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
Figure 73. Daiichi Sankyo, Inc Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
Figure 74. Sanofi Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
Figure 75. Merck Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
Figure 76. Abbott Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5611 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の副腎皮質ホルモン阻害剤市場規模・現状・予測（2021年-2027年）

Global Adrenal Corticosteroid Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-3766 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、副腎皮質ホルモン阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オシロドロスタット、メチラポン）、用途別市場規模（病院、ホームケア、専門センター、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界の腎臓/腎線維化治療市場規模・現状・予測（2021年-2027年）

Global Kidney/Renal Fibrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4404 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腎臓/腎線維化治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンジオテンシンII受容体拮抗薬（ARB）、アンジオテンシン変換酵素（ACE）阻害薬、ピルフェニドン、レニン阻害薬、バソペプチダーゼ阻...

世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年）

Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5815 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ヤヌスキナーゼ（JAK）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ）、用途別市場規模（自己免疫疾患、腫瘍）、主要...

世界の逆転写酵素市場規模・現状・予測（2021年-2027年）

Global Reverse Transcriptase Enzyme Market Size, Status and Forecast 2021-2027
QFJ1-4832 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、逆転写酵素の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（逆転写酵素酵素試薬、逆転写酵素プライマー）、用途別市場規模（病院、バイオテクノロジー企業、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の酵素免疫測定法（ELISA）検査市場規模・現状・予測（2021年-2027年）

Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Status and Forecast 2021-2027
QFJ1-4193 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、酵素免疫測定法（ELISA）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サンドイッチELISA、間接ELISA、マルチポータブルELISA、競合ELISA）、用途別市場規模（病院＆診断センター...

世界のがんCDK阻害剤市場規模・現状・予測（2021年-2027年）

Global Cancer CDK Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-3953 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、がんCDK阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（前臨床、フェーズI、フェーズI / II、フェーズII、フェーズIII）、用途別市場規模（医療機関、科学研究センター）、主要地域別市場規...

世界のヘッジホッグ経路阻害剤市場規模・現状・予測（2021年-2027年）

Global Hedgehog Pathway Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-4292 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ヘッジホッグ経路阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスモデギブ、エリスモデギブ、その他）、用途別市場規模（基底細胞癌（BCC）、急性リンパ芽球性白血病（AML）、その他）、主要地域...

世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年）

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5949 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、PI3キナーゼ（PI3K）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）、用途別市場規模（病院、研究所・研究機関、クリニック、その...

世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年） Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. Market Analysis and Insights: Global BCL-2 (B-cell lympho…
世界の腎臓/腎線維化治療市場規模・現状・予測（2021年-2027年） Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure. Market Analysis and Insights: Global Kidney/…
世界の副腎皮質ホルモン阻害剤市場規模・現状・予測（2021年-2027年） Adrenal corticosteroid inhibitors are a class of therapeutic drugs that are widely used to treat Cushing's syndrome and certain types of solid tumors, such as breast cancer. It exerts its effect by inhibiting the endogenous synthesis of hormones secreted by the adrenal cortex by interfering with the…
世界の逆転写酵素市場規模・現状・予測（2021年-2027年） Reverse transcriptase enzymes are the used to form cDNA (complementary DNA) from a single RNA, complementary DNA is used in duplicate eukaryotic genes in prokaryotes Market Analysis and Insights: Global Reverse Transcriptase Enzyme Market The global Reverse Transcriptase Enzyme market size is projec…
世界の酵素免疫測定法（ELISA）検査市場規模・現状・予測（2021年-2027年） Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Hospitals and diagnostic centers were the major end-users to the ELISA test market. The demand ELISA testing in this end-user segment is mainly due to factors …